ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Daniel R. Rhodes, Jianjun Yu, Shanker Kalyana Sundaram et al. · Neoplasia · 2004
DNA microarray technology has led to an explosion of oncogenomic analyses, generating a wealth of data and uncovering the complex gene expression patterns of cancer. Unfortunately, due to the lack of a unifying bioinformatic resource, the majority of these data sit stagnant and disjointed following publication, massively underutilized by the cancer research community. Here, we present ONCOMINE, a cancer microarray database and web-based data-mining platform aimed at facilitating discovery from genome-wide expression analyses. To date, ONCOMINE contains 65 gene expression datasets comprising nearly 48 million gene expression measurements form over 4700 microarray experiments. Differential expression analyses comparing most major types of cancer with respective normal tissues as well as a variety of cancer subtypes and clinical-based and pathology-based analyses are available for exploration. Data can be queried and visualized for a selected gene across all analyses or for multiple genes in a selected analysis. Furthermore, gene sets can be limited to clinically important annotations including secreted, kinase, membrane, and known gene-drug target pairs to facilitate the discovery of novel biomarkers and therapeutic targets.
Cited by 3,612 works. doi:10.1016/s1476-5586(04)80047-2
Authors
- Daniel R. Rhodes
- Jianjun Yu
- Shanker Kalyana Sundaram
- Nandan Deshpande
- Radhika Varambally
- Debashis Ghosh
- Terrence R. Barrette
- Akhilesh Pander
- Arul M. Chinnaiyan
References
- Gene Ontology: tool for the unification of biology
- KEGG: Kyoto Encyclopedia of Genes and Genomes
- Molecular portraits of human breast tumours
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
- KEGG: Kyoto Encyclopedia of Genes and Genomes
- Gene expression profiling predicts clinical outcome of breast cancer
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
- Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
- Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays